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Abstracts 201Musculoskeletal imaging techniques, especially those non-destructive ones,
such as clinical or laboratory CT, MRI, and ultrasound are able to provide not
only 2-D and 3-D reconstructed images of the related organs or tissues, but
also quantifications of the relevant parameters. The advance bioimaging
technologies developed for the above applications are also extended by
incorporating imaging contrast-enhancement materials. All the data-set
enable us to design 3D tissue or organ structures of our musculoskeletal
system using rapid 3D prototyping technologies. Above imaging technologies
and application protocols also provide an excellent evaluation tools
qualitatively and quantitatively for assessment of the implanted 3-D rapid-
prototyped scaffolds preclinically and clinically. Multidisciplinary collabora-
tions with biomedical engineers, biomaterial engineers, basic and clinical
scientists are essential.
The author’s group has been using a unique low temperature 3D rapid-
prototyping technology to design and produce bioactive and degradable
bone scaffold composite materials. Innovative bioactive materials are from
nature herbs, biological factors, and cost-effective biometallic elements.
Clinical indication-orientated animal models have been established for
preclinical evaluations. Efforts are made for optimization of the implantable
products to ensure maximal biocompatibility and osteoconductivity with
sufficient mechanical properties.
Additional efforts are also be made towards translational medicine, here
refer to product registration and multi-center clinical trials for innovative
rapid-prototyped 3D skeletal scaffolds before becoming commercial avail-
able products for our routine clinical applications.
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Erin Hildebrandt, David Hanley
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Osteoporotic fractures are associated with considerable morbidity and
mortality, and the use of 3D high resolution imaging has offered new
opportunities to learn about bone quality that may help in the development
of novel treatments and diagnostic techniques aimed at improving bonehealth. The advent of high-resolution peripheral quantitative computed
tomography scanners (HR-pQCT, XtremeCT, Scanco Medical) a decade ago
opened new opportunities to investigate natural changes in bone quality
with aging, the effects of treatments on the underlying bone micro-
architecture, and the ability to apply techniques such as the finite element
analysis to non-invasively assess bone strength. In the past year, a new
version of HR-pQCT has become available (XtremeCTII) which further
advances the potential to assess bone quality.
In this work we present our population-based cohort that has been a major
focus of our laboratory over the past decade. We have previously established
the age-related changes in bone microarchitecture based on a cross-
sectional study design recently, and here we begin to explore the longitu-
dinal analysis of that same population, and use that information to under-
stand the true individual age-related changes in bone architecture. With the
newfound ability to measure at a 61 mm voxel size (Fig. 1), we explore the
challenges of having a continuity of research studies that will span two
generations of these systems. Specially, we will address the major issues
that need to be resolved so that the wealth of longitudinal data collected by
all users of HR-pQCT can be effectively continued. Also, we explore the
ability to apply advanced analysis methods to the new technology, including
both the finite element method and direct measures of bone microarchi-
tecture. Finally, we will demonstrate the potential to being studying bone
quality for other research applications, such as the periarticular bone
quality at the knee and elbow, which is important for learning about
diseases such as osteoarthritis and with implications for total joint
replacement. In summary, the introduction of new HR-pQCT technology
offers exciting new opportunities for the study of bone quality.
Brief CV
Research Area(s): Biomedical engineering
Technical Expertise: Imaging, quantitative analysis
Email: skboyd@ucalgary.ca
Website: http://bonelab.ucalgary.ca
Dr. Boyd is a Professor of Biomedical Engineering in the Faculty of Medicine
performing research in the area of osteoporosis, with a particular focus on
bone microarchitecture and non-invasive estimation of strength. He has
published over sixty journal articles and had continuous funding from Cana-
dian national agencies (e.g., CIHR, NSERC) since his appointment at the
University of Calgary in 2002. His research ranges from in vivo mCT studies
showing bone microarchitectural development in animal models of osteopo-
rosis, to clinical research using recently developed HR-pQCT. He co-leads a
Calgary-based population study using HR-pQCT to determine normative bone
microarchitecture and strength across the lifespan in both sexes. He is
appointed a Senior Scholar by Alberta Innovates e Health Solutions, the Bob
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McCaig Institute for Bone and Joint Research with cross appointments in the
Faculty of Kinesiology and Schulich School of Engineering.
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HR-PQCT IN CLINICAL RHEUMATOID ARTHRITIS
Lai-shan Tam
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HR-pQCT has been used to define cortical and trabecular bone changes at
different anatomical sites involved in the disease processes of rheumatoid
arthritis (RA), which include the distal radius, the proximal interphalangeal
joints and the metacarpophalangeal joints. Three HR-pQCT studies have
shown that RA is associated with a significant reduction in cortical and
trabecular volumetric bone mineral density (vBMD), microstructure and
biomechanical indices at the distal radius compared to controls. Inflamma-
tion-associated increased bone resorptive activity produces greater deficits
in cortical than trabecular bone, and the changes were more pronounced
than those revealed by areal BMD (aBMD), independent of body weight,
hormonal level and aBMD. Changes in density and microstructure in RA
patients correlated with disease activity, disease severity and serum levels
of proinflammatory cytokines.
HR-pQCT is also useful for defining the anatomical sites prone to develop bone
erosions aswell as to quantify the size of such erosions. Boneerosions of>2mm
width in cortical break have been identified as highly specific for inflammatory
joint diseases. The pathogenesis of these lesions is unclear, but mechanical
forcesmight beconsidered as the potential triggers. Furthermore,HR-pQCThas
been helpful in validating the capability of other imaging techniques, such as
MRI and ultrasonography, in detecting bone erosions. HR-pQCT has been shown
to be particularly useful in monitoring the dynamics of individual bone erosions
and their responsiveness to treatment. Repair processes of existing bone
erosions have been studied in a longitudinal manner and were identified in
patients with RA treated with cytokine-blocking agents such as the TNF
inhibitors as well as the IL-6-receptor blocker tocilizumab.
Aside from bone erosions, HR-pQCT is also useful for visualizing early
nonerosive cortical bone changes in patients with RA. Areas of the
periarticular bone where the cortical lining is thin and porous (cortical
fenestration) have been defined by HR-pQCT. In patients with RA-specific
autoantibodies against citrullinated proteins, such lesions have also been
identified before they develop inflammatory disease, suggesting that bone is
altered by autoimmunity in patients with RA before inflammation emerges,
and creates new concepts in understanding the pathogenesis of RA.
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MOLECULAR IMAGING TECHNOLOGIES FOR OSTEOARTHRITIS/
RHEUMATOID ARTHRITIS STUDIES
Lian-ping Xing
Department of Pathology, University of Rochester, USAArthritis, including rheumatoid arthritis and osteoarthritis, is a common
disease affecting millions of people worldwide. Murine models of arthritis are
an important tool for both the preclinical study of arthritis pathogenesis and
the testing the efficacy of anti-arthritis drugs, which have significantly
advanced our understanding of arthritis. However, they are limited by a lack
of longitudinal translational outcome measures of disease progression or
interventional therapy. This issue presents 3 problems for prototypical
preclinical investigations of drug effects on inflammation and tissue damages:
1) most cross-sectional studies in mice with “established arthritis” do not
include an objective assessment of disease severity prior to treatment, and
neither rates of change nor healing responses can be assessed; 2) the
commonly used end points (i.e., histology and ex vivo molecular analyses)
require the death of themice, thusmarkedly increasing the number of animals
needed to assess efficacy at multiple time points; 3) although the incidence
and severity of arthritis vary among genetically identical littermates, there
are no established scoring criteria to stratify different groups ofmice based on
disease activity in an intervention study. To overcome these problems, our
group recently developed several imaging techniques based on their clinically
used protocols. These techniques include contrast-enhanced magnetic
resonance imaging, near-infrared lymphatic imaging, and Power Doppler
ultrasound, which allow us to assess disease activity and progression in vivo in
arthritic mice longitudinally. We used these in vivo imaging techniques in TNF
transgenic mice, a mouse model of rheumatoid arthritis, and a Meniscal
Ligamentous Injury-induced mouse model of osteoarthritis to study the
association between synovial lymphatic draining function and the develop-
ment and progression of joint lesions in these mice, as well as the in responses
to a lymphatic based therapy. In this presentation, Iwill present ourwork using
these imaging techniques. I will also introduce recently developed near-
infrared dye based molecular imaging in preclinical arthritis study. Thus,
molecular imaging technologies will greatly enhance the utility of murine
models of arthritis in biological research.
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